BioAge Labs (BIOA) Long-Term Debt Issuances (2023 - 2026)
BioAge Labs (BIOA) posted Long-Term Debt Issuances of $1.5 million for Q1 2026, little changed sequentially from $1.5 million in Q4 2025, and little changed YoY from $1.5 million in Q1 2025.
BioAge Labs (BIOA) Long-Term Debt Issuances (2023 - 2026) Analysis & Trends
BioAge Labs has reported Long-Term Debt Issuances for 4 years, with the latest figure at $1.5 million in Q1 2026.
- Quarterly Long-Term Debt Issuances changed 0.0% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $6.0 million, changed 0.0% from the prior year.
- Long-Term Debt Issuances steadied at $1.5 million in Q1 2026 per BIOA's latest filing, from $1.5 million in the prior quarter.
- Over five years, Long-Term Debt Issuances peaked at $1.5 million in Q1 2024 and troughed at -$11.5 million in Q4 2023.
- A 4-year average of $200000.0 and a median of $1.5 million in 2024 frame the typical range for Long-Term Debt Issuances.
- The sharpest annual moves came in 2024 and 2025: Long-Term Debt Issuances surged 113.04% in 2024, then changed 0.0% in 2025.
- Over 4 years, Long-Term Debt Issuances stood at -$11.5 million in 2023, then soared by 113.04% to $1.5 million in 2024, then changed by 0.0% to $1.5 million in 2025, then changed by 0.0% to $1.5 million in 2026.
- According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $1.5 million, $1.5 million, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | BioAge Labs | 434.04 Mn | 434.04 Mn | -14.23 Mn | 500,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 500,000.00 |
| Jun 30, 2026 | 500,000.00 |
| Mar 31, 2026 | 1.50 Mn |
| Mar 31, 2026 | 1.50 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.50 Mn |